Is an Elevated PSA Always a Sign of Prostate Cancer?

September is Prostate Cancer Awareness Month, and one of the most common points of confusion is what a high result on a prostate-specific antigen (PSA) blood test means. An elevated PSA is a reason to look closer. It is not a diagnosis.

What a PSA test measures

PSA is a protein made by the prostate, and the blood test measures how much of it is circulating. Doctors use it as the first step when screening for prostate cancer. But PSA is not specific to cancer. The American Urological Association (AUA) notes that the commonly cited cutoff of 4 nanograms per milliliter (ng/mL) comes from early studies of men thought to be free of prostate cancer, and other research has used 3 ng/mL. No single number cleanly separates “normal” from “cancer.”

What else can raise PSA

An elevated PSA can be caused by prostate cancer but also by an enlarged prostate, known as benign prostatic hyperplasia (BPH), and by inflammation of the prostate, called prostatitis. Urinary tract infections and recent procedures involving the prostate can also raise levels. Some medicines used to treat prostate enlargement, including finasteride and dutasteride, lower PSA, so doctors use a lower cutoff for men who take them.

That variability means false positives are common. In one major trial of men screened every two to four years, more than 15% had at least one false-positive result over 10 years, according to the U.S. Preventive Services Task Force.

What a high result can look like in practice

A 10-year review of routine screening at one Michigan primary care clinic shows how varied the outcomes can be. Among 1,258 men ages 55 to 70, about 10% had a PSA of 4 ng/mL or higher. Of those, 18 men were confirmed to have prostate cancer on biopsy, about 1.4% of everyone screened. Others had explanations such as BPH, infection or prostatitis, and some saw their PSA return to normal on a repeat test. It is a single-clinic study, but it illustrates why a high number is the start of a workup, not the end of one.

What usually happens after a high result

Current AUA guidance says a newly elevated PSA should be repeated before a doctor orders additional biomarker tests, imaging or a biopsy. The National Cancer Institute says a repeat test is often suggested in six to eight weeks to confirm the original finding.

If the number stays high, a doctor may continue watching it with repeat PSA tests and a digital rectal exam. If PSA keeps climbing, especially quickly, or if a lump is found, next steps can include blood or urine biomarker tests and imaging such as MRI or micro-ultrasound. AUA guidance also says a rise in PSA over time should not be the only reason to order more testing, and that a biopsy can be put off when a validated risk assessment suggests a low likelihood of clinically significant cancer.

When to start the conversation about screening

The AUA and the Society of Urologic Oncology released a 2026 amendment to their early detection guideline that emphasizes shared decision-making, meaning the doctor and patient talk through risks, benefits and preferences before testing. For men at standard risk, a baseline PSA is recommended at ages 45 to 50. Men at higher risk, including those with Black ancestry, inherited gene mutations or a strong family history, should be offered screening at ages 40 to 45. For men ages 50 to 69, screening is offered every two to four years. Intervals can be personalized or stopped based on age, PSA level, overall health and life expectancy.

Why the conversation matters

The American Cancer Society estimates that about 333,830 men will be diagnosed with prostate cancer in the United States in 2026 and that 36,320 will die from it. Timing matters. Five-year relative survival approaches 100% for the 83% of men diagnosed with localized or regional disease but falls to 38% for those diagnosed at a distant stage. Black men face an incidence rate 67% higher than White men and are about twice as likely to die from prostate cancer.

A health care professional can explain what a person’s own result means in the context of their age, family history and overall risk. This article is for educational purposes and is not a substitute for medical advice.